![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Grapefruit juice lets patients take lower dose of cancer drug
A glass a day of grapefruit juice lets patients derive the same benefits from...
Lundbeck on track to meet financial expectations and renew its product portfolio
H. Lundbeck A/S (Lundbeck) reports first half revenue of DKK 6,829 million, excluding Lexapro®...
Bristol-Myers Squibb Foundation awards $1.6 million in grants
The Bristol-Myers Squibb Foundation announced $1.6 million in grants to four health care institutions...
AcelRx sufentanil NanoTab pain products gain additional US patents
The US Patent and Trademark Office (USPTO) has issued two additional patents to AcelRx Pharmaceuticals'...
Rejected Alzheimer’s drug shows new potential
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered...
Trial signals major milestone in hunt for new TB drugs
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared...
Roche reports second positive study of RoACTEMRA given by subcutaneous injection to patients with...
Roche announced that the BREVACTA study of RoACTEMRA (tocilizumab, known as ACTEMRA outside Europe) given...
Novartis begins shipment of Fluvirin influenza seasonal vaccine in US
Novartis has commenced shipment of Fluvirin influenza vaccine for the 2012-2013 influenza season, in the...
GSK wins FDA priority review for Promacta supplemental new drug application
GlaxoSmithKline, Ligand Pharmaceuticals' partner, has gained FDA priority review status for the supplemental new...
Catalent begins supply of Abilify antipsychotic drug to Otsuka Pharma
Catalent has started supplying its antipsychotic drug, Abilify, an orally disintegrating tablet (ODT) to...